Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Middle East & Africa Breast Cancer Therapeutics Market - Key Industry Dynamics

4.1 Key Market Drivers

4.1.1 Growing Burden of Breast Cancer

4.1.2 Launch of Several Diagnostics and Screening Programs

4.2 Key Market Restraints

4.2.1 High Cost of Diagnosis and Treatment

4.3 Key Market Opportunities

4.3.1 Increased Support from Government and Private Organizations

4.4 Key Future Trends

4.4.1 Increasing Use of Personalized Medicine

4.5 Impact Analysis:

5. Breast Cancer Therapeutics Market - Middle East & Africa Market Analysis

5.1 Middle East & Africa Breast Cancer Therapeutics Market Revenue (US$ Mn), 2022 - 2030

6. Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 - by Drug Therapy

6.1 Overview

6.2 Middle East & Africa Breast Cancer Therapeutics Market Revenue Share, by Drug Therapy, 2022 & 2030 (%)

6.3 Targeted Drug Therapy

6.3.1 Overview

6.3.2 Targeted Drug Therapy: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

6.3.2.1 Middle East & Africa Breast Cancer Therapeutics Market, by Targeted Drug Therapy, 2020-2030 (US$ Million)

6.4 Hormonal Drug Therapy

6.4.1 Overview

6.4.2 Hormonal Drug Therapy: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

6.4.2.1 Middle East & Africa Breast Cancer Therapeutics Market, by Hormonal Drug Therapy, 2020-2030 (US$ Million)

6.5 Chemotherapy

6.5.1 Overview

6.5.2 Chemotherapy: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

6.6 Immunotherapy/ Biological Therapy

6.6.1 Overview

6.6.2 Immunotherapy/ Biological Therapy: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

7. Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 - by Breast Cancer Type

7.1 Overview

7.2 Middle East & Africa Breast Cancer Therapeutics Market Revenue Share, by Breast Cancer Type, 2022 & 2030 (%)

7.3 Hormone Receptor

7.3.1 Overview

7.3.2 Hormone Receptor: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

7.4 HER2+ (human epidermal growth factor receptor 2)

7.4.1 Overview

7.4.2 HER2+: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

7.5 Triple-Negative Breast Cancer

7.5.1 Overview

7.5.2 Triple-Negative Breast Cancer: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

8. Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 - by Distribution Channel

8.1 Overview

8.2 Middle East & Africa Breast Cancer Therapeutics Market Revenue Share, by Distribution Channel, 2022 & 2030 (%)

8.3 Hospital Pharmacies

8.3.1 Overview

8.3.2 Hospital Pharmacies: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Drug Store and Retail Pharmacies

8.4.1 Overview

8.4.2 Drug Store and Retail Pharmacies: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

8.5 Online Pharmacies

8.5.1 Overview

8.5.2 Online Pharmacies: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

9. Middle East & Africa Breast Cancer Therapeutics Market -Country Analysis

9.1 Middle East & Africa Breast Cancer Therapeutics Market, Revenue and Forecast to 2030

9.1.1 Overview

9.1.2 Middle East & Africa Breast Cancer Therapeutics Market, Breakdown, by Country- Revenue (2022) (US$ Million)

9.1.3 Middle East & Africa Breast Cancer Therapeutics Market, by Countries, 2022 and 2030 (%)

9.1.3.1 Saudi Arabia

9.1.3.1.1 Saudi Arabia Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)

9.1.3.1.2 Saudi Arabia: Breast Cancer Therapeutics Market, by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.1.2.1 Saudi Arabia: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.1.2.2 Saudi Arabia: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.1.3 Saudi Arabia: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020-2030 (US$ Million)

9.1.3.1.4 Saudi Arabia: Breast Cancer Therapeutics Market, by Distribution Channel, 2020-2030 (US$ Million)

9.1.3.2 UAE

9.1.3.2.1 UAE Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)

9.1.3.2.2 UAE: Breast Cancer Therapeutics Market, by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.2.2.1 UAE: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.2.2.2 UAE: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.2.3 UAE: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020-2030 (US$ Million)

9.1.3.2.4 UAE: Breast Cancer Therapeutics Market, by Distribution Channel, 2020-2030 (US$ Million)

9.1.3.3 South Africa

9.1.3.3.1 South Africa Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)

9.1.3.3.2 South Africa: Breast Cancer Therapeutics Market, by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.3.2.1 South Africa: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.3.2.2 South Africa: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.3.3 South Africa: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020-2030 (US$ Million)

9.1.3.3.4 South Africa: Breast Cancer Therapeutics Market, by Distribution Channel, 2020-2030 (US$ Million)

9.1.3.4 Rest of Middle East & Africa

9.1.3.4.1 Rest of Middle East & Africa Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)

9.1.3.4.2 Rest of Middle East & Africa: Breast Cancer Therapeutics Market, by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.4.2.1 Rest of Middle East & Africa: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.4.2.2 Rest of Middle East & Africa: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.4.3 Rest of Middle East & Africa: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020-2030 (US$ Million)

9.1.3.4.4 Rest of Middle East & Africa: Breast Cancer Therapeutics Market, by Distribution Channel, 2020-2030 (US$ Million)

10. Breast Cancer Therapeutics Market-Industry Landscape

10.1 Overview

10.2 Growth Strategies in Breast Cancer Therapeutics Market

10.3 Organic Growth Strategies

10.3.1 Overview

10.4 Inorganic Growth Strategies

10.4.1 Overview

11. Company Profiles

11.1 Eli Lilly and Co

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 Eisai Co Ltd

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 Novartis AG

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 AstraZeneca Plc

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 Pfizer Inc

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Gilead Sciences Inc

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 Merck & Co Inc

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 Teva Pharmaceutical Industries Ltd

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Products and Services

11.8.4 Financial Overview

11.8.5 SWOT Analysis

11.8.6 Key Developments

11.9 Amgen Inc

11.9.1 Key Facts

11.9.2 Business Description

11.9.3 Products and Services

11.9.4 Financial Overview

11.9.5 SWOT Analysis

11.9.6 Key Developments

12. Appendix

12.1 About Us

12.2 Glossary of Terms

List of Tables

Table 1. Middle East & Africa Breast Cancer Therapeutics Market Segmentation

Table 2. Middle East & Africa Breast Cancer Therapeutics Market, by Targeted Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 3. Middle East & Africa Breast Cancer Therapeutics Market, by Hormonal Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 4. Saudi Arabia Breast Cancer Therapeutics Market, by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 5. Saudi Arabia Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 6. Saudi Arabia Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 7. Saudi Arabia Breast Cancer Therapeutics Market, by Breast Cancer Type - Revenue and Forecast to 2030 (US$ Million)

Table 8. Saudi Arabia Breast Cancer Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)

Table 9. UAE Breast Cancer Therapeutics Market, by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 10. UAE Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 11. UAE Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 12. UAE Breast Cancer Therapeutics Market, by Breast Cancer Type - Revenue and Forecast to 2030 (US$ Million)

Table 13. UAE Breast Cancer Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)

Table 14. South Africa Breast Cancer Therapeutics Market, by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 15. South Africa Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 16. South Africa Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 17. South Africa Breast Cancer Therapeutics Market, by Breast Cancer Type - Revenue and Forecast to 2030 (US$ Million)

Table 18. South Africa Breast Cancer Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)

Table 19. Rest of Middle East & Africa Breast Cancer Therapeutics Market, by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 20. Rest of Middle East & Africa Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 21. Rest of Middle East & Africa Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 22. Rest of Middle East & Africa Breast Cancer Therapeutics Market, by Breast Cancer Type - Revenue and Forecast to 2030 (US$ Million)

Table 23. Rest of Middle East & Africa Breast Cancer Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)

Table 24. Recent Organic Growth Strategies in Breast Cancer Therapeutics Market

Table 25. Recent Inorganic Growth Strategies in the Breast Cancer Therapeutics Market

Table 26. Glossary of Terms, Breast Cancer Therapeutics Market

List of Figures

Figure 1. Middle East & Africa Breast Cancer Therapeutics Market Segmentation, By Country

Figure 2. Middle East & Africa Breast Cancer Therapeutics Market - Key Industry Dynamics

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Middle East & Africa Breast Cancer Therapeutics Market Revenue (US$ Mn), 2022 - 2030

Figure 5. Middle East & Africa Breast Cancer Therapeutics Market Revenue Share, by Drug Therapy, 2022 & 2030 (%)

Figure 6. Targeted Drug Therapy: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Hormonal Drug Therapy: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Chemotherapy: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. Immunotherapy/ Biological Therapy: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 10. Middle East & Africa Breast Cancer Therapeutics Market Revenue Share, by Breast Cancer Type, 2022 & 2030 (%)

Figure 11. Hormone Receptor: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. HER2+: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. Triple-Negative Breast Cancer: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Middle East & Africa Breast Cancer Therapeutics Market Revenue Share, by Distribution Channel, 2022 & 2030 (%)

Figure 15. Hospital Pharmacies: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Drug Store and Retail Pharmacies: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Online Pharmacies: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. Middle East & Africa Breast Cancer Therapeutics Market, by Key Country - Revenue (2022) (US$ Million)

Figure 19. Middle East & Africa Breast Cancer Therapeutics Market, By Key Countries, 2022 and 2030 (%)

Figure 20. Saudi Arabia Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)

Figure 21. UAE Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)

Figure 22. South Africa Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)

Figure 23. Rest of Middle East & Africa Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)

Figure 24. Growth Strategies in Breast Cancer Therapeutics Market